• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的早发性和晚发性强迫症患者的血清素转运体可用性。

The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.

机构信息

Department of Nuclear Medicine, University of Leipzig, Germany.

出版信息

Int J Neuropsychopharmacol. 2011 Jun;14(5):606-17. doi: 10.1017/S1461145710001604. Epub 2011 Jan 14.

DOI:10.1017/S1461145710001604
PMID:21232166
Abstract

The pathogenetic role of central serotonin transporters (SERT) in obsessive-compulsive disorder (OCD) has been investigated in vivo by positron emission tomography (PET) or single-photon emission computed tomography (SPECT) studies with inconsistent results. This might reflect methodological differences but possibly also the pathophysiological heterogeneity of the disorder, i.e. the age at onset of OCD. The aim of our study was to compare SERT availability in patients with OCD to healthy controls (HC) taking into account the onset type, other factors and covariates (e.g. SERT genotype, age, depression level, gender). We studied 19 drug-naive OCD patients (36±13 yr, eight females) with early onset (EO-OCD, n=6) or with late onset (LO-OCD, n=13), and 21 HC (38±8 yr, nine females) with PET and the SERT-selective radiotracer [11C]DASB. Statistical models indicated that a variety of covariates and their interaction influenced SERT availability measured by distribution volume ratios (DVR). These models revealed significant effects of onset type on DVR with lower values in LO-OCD (starting at age 18 yr) compared to EO-OCD and HC in limbic (e.g. the amygdala), paralimbic brain areas (the anterior cingulate cortex), the nucleus accumbens and striatal regions, as well as borderline significance in the thalamus and the hypothalamus. The putamen, nucleus accumbens and hypothalamus were found with significant interaction between two SERT gene polymorphisms (SERT-LPR and VNTR). These findings suggest that late but not early onset of OCD is associated with abnormally low SERT availability. In part, functional polymorphisms of the SERT gene might determine the differences.

摘要

中枢 5-羟色胺转运体(SERT)在强迫症(OCD)中的致病作用已经通过正电子发射断层扫描(PET)或单光子发射计算机断层扫描(SPECT)研究进行了体内研究,但结果不一致。这可能反映了方法学上的差异,但也可能反映了该疾病的病理生理异质性,即 OCD 的发病年龄。我们的研究目的是比较 OCD 患者和健康对照者(HC)的 SERT 可用性,同时考虑发病类型、其他因素和协变量(例如 SERT 基因型、年龄、抑郁水平、性别)。我们研究了 19 名未经药物治疗的 OCD 患者(36±13 岁,8 名女性),其中 6 名患者为早发性(EO-OCD),13 名患者为晚发性(LO-OCD),并对 21 名 HC(38±8 岁,9 名女性)进行了 PET 和 SERT 选择性放射性示踪剂 [11C]DASB 研究。统计模型表明,多种协变量及其相互作用影响了通过分布容积比(DVR)测量的 SERT 可用性。这些模型显示,发病类型对 DVR 有显著影响,LO-OCD(发病年龄为 18 岁)的 DVR 值低于 EO-OCD 和 HC,在边缘(如杏仁核)、边缘旁脑区(前扣带皮层)、伏隔核和纹状体区域,以及丘脑和下丘脑的结果接近显著。纹状体、伏隔核和下丘脑的结果与 SERT 基因两个多态性(SERT-LPR 和 VNTR)之间存在显著的相互作用。这些发现表明,迟发性但不是早发性 OCD 与 SERT 可用性异常降低有关。部分原因可能是 SERT 基因的功能多态性决定了这些差异。

相似文献

1
The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.未经治疗的早发性和晚发性强迫症患者的血清素转运体可用性。
Int J Neuropsychopharmacol. 2011 Jun;14(5):606-17. doi: 10.1017/S1461145710001604. Epub 2011 Jan 14.
2
Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.强迫症患者的血清素和多巴胺转运体成像
Psychiatry Res. 2005 Oct 30;140(1):63-72. doi: 10.1016/j.pscychresns.2005.07.002. Epub 2005 Oct 6.
3
Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.强迫症患者接受依地普仑治疗后 5-羟色胺转运体结合潜能的改变:[11C]DASB PET 研究。
Psychol Med. 2016 Jan;46(2):357-66. doi: 10.1017/S0033291715001865. Epub 2015 Oct 1.
4
Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.强迫症患者服用氯米帕明期间丘脑-下丘脑5-羟色胺转运体可用性的变化。
Neuropsychopharmacology. 2008 Dec;33(13):3126-34. doi: 10.1038/npp.2008.35. Epub 2008 Mar 19.
5
[123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.[123I]-β-羧基-3β-(4-碘苯基)托烷单光子发射计算机断层扫描成像显示,24名未服用药物的强迫性检查者丘脑-下丘脑5-羟色胺转运体可用性降低。
Neuropsychopharmacology. 2007 Aug;32(8):1661-8. doi: 10.1038/sj.npp.1301290. Epub 2006 Dec 27.
6
Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.强迫症患者岛叶皮质中 5-羟色胺转运体结合减少:一项 [11C]DASB PET 研究。
Neuroimage. 2010 Jan 1;49(1):121-6. doi: 10.1016/j.neuroimage.2009.07.069. Epub 2009 Aug 4.
7
Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [ C]DASB PET study.接受艾司西酞普兰治疗的早发性强迫症患者中血清素转运体可用性更高:一项[C]DASB正电子发射断层扫描研究。
Hum Psychopharmacol. 2018 Jan;33(1). doi: 10.1002/hup.2642. Epub 2017 Dec 6.
8
Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.强迫症中的5-羟色胺转运体:一项使用[(11)C]McN 5652的正电子发射断层扫描研究
Biol Psychiatry. 2003 Dec 15;54(12):1414-21. doi: 10.1016/s0006-3223(03)00544-4.
9
Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.强迫症患者中血清素转运体可用性降低与症状严重程度相关——一项[11C]DASB正电子发射断层扫描研究。
J Neural Transm (Vienna). 2007;114(12):1603-9. doi: 10.1007/s00702-007-0785-6. Epub 2007 Aug 22.
10
Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder.强迫行为犬中 5-羟色胺 2A 受体、5-羟色胺转运体和多巴胺转运体的改变,有望成为人类强迫症的模型。
Psychiatry Res. 2012 Jan 30;201(1):78-87. doi: 10.1016/j.pscychresns.2011.06.006. Epub 2012 Jan 27.

引用本文的文献

1
PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation.正电子发射断层扫描(PET)成像揭示精神疾病中的神经炎症机制:从微胶质细胞激活到治疗创新。
Mol Neurobiol. 2025 Jul 4. doi: 10.1007/s12035-025-05177-w.
2
Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings.强迫症的血清素能基础:神经影像学研究结果的系统评价与荟萃分析
Psychiatry Clin Neurosci. 2025 Feb;79(2):48-59. doi: 10.1111/pcn.13760. Epub 2024 Nov 7.
3
Psilocybin in pharmacotherapy of obsessive-compulsive disorder.
迷幻蘑菇在强迫症药物治疗中的应用。
Pharmacol Rep. 2024 Oct;76(5):911-925. doi: 10.1007/s43440-024-00633-1. Epub 2024 Aug 1.
4
Cortical gyrification differences between early- and late-onset obsessive-compulsive disorder: neurobiological evidence for neurodevelopmentally distinct subtypes.早发性和晚发性强迫症患者皮质脑回差异:神经发育亚型的神经生物学证据。
Psychol Med. 2023 Oct;53(13):5976-5985. doi: 10.1017/S0033291722003129. Epub 2022 Oct 19.
5
Serotonin Modulates the Correlations between Obsessive-compulsive Trait and Heart Rate Variability in Normal Healthy Subjects: A SPECT Study with [I]ADAM and Heart Rate Variability Measurement.血清素调节正常健康受试者强迫特质与心率变异性之间的相关性:一项使用[I]ADAM和心率变异性测量的单光子发射计算机断层扫描研究。
Clin Psychopharmacol Neurosci. 2022 May 31;20(2):271-278. doi: 10.9758/cpn.2022.20.2.271.
6
Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder.磁共振波谱(MRS)和正电子发射断层扫描(PET)在强迫症中的成像。
Curr Top Behav Neurosci. 2021;49:231-268. doi: 10.1007/7854_2020_201.
7
Inflammation, Obsessive-Compulsive Disorder, and Related Disorders.炎症、强迫症及相关障碍。
Curr Top Behav Neurosci. 2021;49:31-53. doi: 10.1007/7854_2020_210.
8
False positive rates in positron emission tomography (PET) voxelwise analyses.正电子发射断层扫描(PET)体素分析中的假阳性率。
J Cereb Blood Flow Metab. 2021 Jul;41(7):1647-1657. doi: 10.1177/0271678X20974961. Epub 2020 Nov 26.
9
Neural bases of the clinical and neurocognitive differences between earlyand late-onset obsessive–compulsive disorder.早发性和晚发性强迫症的临床和神经认知差异的神经基础。
J Psychiatry Neurosci. 2020 Jul 1;45(4):234-242. doi: 10.1503/jpn.190028.
10
Serotonin system gene variants and regional brain volume differences in pediatric OCD.儿童强迫症中 5-羟色胺系统基因变异与脑区体积差异
Brain Imaging Behav. 2020 Oct;14(5):1612-1625. doi: 10.1007/s11682-019-00092-w.